We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

An Errant Critique That Misses the Mark

Robert T. Chen, MD, MA; Steve Rosenthal, MD, MPH
Arch Pediatr Adolesc Med. 1996;150(5):464-465. doi:10.1001/archpedi.1996.02170300018004.
Text Size: A A A
Published online


DR Brown UNFORTUNATELY seemed to have seen the trees but lost sight of the forest in his critique of our article.1 He correctly identified many of the caveats of the Vaccine Adverse Event Reporting System (VAERS), which we have discussed elsewhere2,3 and cited in this article. These shortcomings, such as underreporting, difficulty in determining causal relationship, and lack of precise denominators, are true for all such essentially passive monitoring systems for adverse events after pharmaceutic interventions. An entire new field, pharmacoepidemiology, has sprung into being during the last decade to try to address these difficult issues, which we have attempted to apply to vaccines.3 Nevertheless, almost all of the shortcomings Dr Brown identified would apply equally to VAERS reports after either whole-cell or acellular pertussis vaccinations. The final comparison in VAERS between the 2 vaccines, while not perfectly precise, should still provide accurate relative qualitative and quantitative


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.